These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17015875)
41. [E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats]. Yamaguchi K; Oka M; Nishino M; Hanasato N; Kira S; Fukuchi Y Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):23-8. PubMed ID: 9611972 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension. Watanabe H Intern Med; 2004 Oct; 43(10):891-3. PubMed ID: 15575233 [No Abstract] [Full Text] [Related]
43. Sildenafil in the treatment of pulmonary hypertension. Barnett CF; Machado RF Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595 [TBL] [Abstract][Full Text] [Related]
44. Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much? Burnett AL Eur Urol; 2006 Jul; 50(1):29-30. PubMed ID: 16567036 [No Abstract] [Full Text] [Related]
45. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227 [TBL] [Abstract][Full Text] [Related]
46. High altitude sickness. Med Lett Drugs Ther; 1992 Sep; 34(878):84-6. PubMed ID: 1508071 [No Abstract] [Full Text] [Related]
47. Comet tails in high-altitude pulmonary edema: diagnostic portent or streak in the sky? Luks AM; Swenson ER Chest; 2007 Apr; 131(4):951-3. PubMed ID: 17426194 [No Abstract] [Full Text] [Related]
48. [Mountaineering and altitude sickness]. Maggiorini M Ther Umsch; 2001 Jun; 58(6):387-93. PubMed ID: 11441701 [TBL] [Abstract][Full Text] [Related]
49. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688 [TBL] [Abstract][Full Text] [Related]
50. [Who gets altitude sickness?]. Bärtsch P Schweiz Med Wochenschr; 1992 Feb; 122(9):307-14. PubMed ID: 1546281 [TBL] [Abstract][Full Text] [Related]
51. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. Hotston M; Shukla N; Bloor J; Persad R; Jeremy JY BJU Int; 2006 Dec; 98(6):1331-2. PubMed ID: 17125493 [No Abstract] [Full Text] [Related]
52. FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A). Lines TC; Ono M Phytomedicine; 2006 Mar; 13(4):236-9. PubMed ID: 16492525 [TBL] [Abstract][Full Text] [Related]
54. Can patients with pulmonary hypertension travel to high altitude? Luks AM High Alt Med Biol; 2009; 10(3):215-9. PubMed ID: 19775210 [TBL] [Abstract][Full Text] [Related]
55. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction. Manganiello V Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126 [No Abstract] [Full Text] [Related]
56. PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension. Deibert P; Bremer H; Roessle M; Kurz-Schmieg AK; Kreisel W Eur Respir J; 2007 Jan; 29(1):220-1. PubMed ID: 17197488 [No Abstract] [Full Text] [Related]
57. Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye? Verit A Med Hypotheses; 2007; 69(2):470-1. PubMed ID: 17280789 [No Abstract] [Full Text] [Related]
58. Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED. Boyle CD; Xu R; Asberom T; Chackalamannil S; Clader JW; Greenlee WJ; Guzik H; Hu Y; Hu Z; Lankin CM; Pissarnitski DA; Stamford AW; Wang Y; Skell J; Kurowski S; Vemulapalli S; Palamanda J; Chintala M; Wu P; Myers J; Wang P Bioorg Med Chem Lett; 2005 May; 15(9):2365-9. PubMed ID: 15837326 [TBL] [Abstract][Full Text] [Related]
59. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132 [TBL] [Abstract][Full Text] [Related]
60. [Visiting high altitudes--healthy persons and patients with risk diseases]. Fischer R MMW Fortschr Med; 2004 Feb; 146(8):33-4, 36-7. PubMed ID: 15346935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]